Aeropay | $20,000,000 | (May 17, 2024)
Bedrock Materials | $9,000,000 | (May 17, 2024)
OTPLESS | $3,500,000 | (May 17, 2024)
Arzeda
United States
- Seattle, WA - Washington
- 04/04/2022
- Series B
- $33,000,000
Arzeda, The Protein Design Company™, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com.
- Industry Biotechnology
- Website https://www.arzeda.com/
- LinkedIn https://www.linkedin.com/company/arzeda-corp/
Related People
Alexandre ZanghelliniCo Founder
United Kingdom -
Seattle, Washington,
Alexandre Zanghellini co-founded Arzeda and currently serves as its Chief Executive Officer. He leads Arzeda’s product and technology development and corporate strartegy. Alex is one of the key inventors of Arzeda’s synthetic biology platform for novel enzyme and metabolic pathway design and is a keen believer in the power of biotechnology to solve some of our biggest societal challenges. Before founding Arzeda, Alex held positions in research and development both in academia and industry. He holds a Ph.D. in biochemistry from the University of Washington in Seattle, a M.Sc. Eng. in computer engineering from ENSTA/ParisTech and a MS in computer science from the University of Paris Pierre et Marie Curie/Paris VI.
ekko | $2,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
HEPHAISTOS-Pharma | $11,189,199 | (May 17, 2024)
Keyper | $4,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
Angel AI | $4,750,000 | (May 17, 2024)
InstaAstro | $2,300,000 | (May 17, 2024)
Fay | $25,000,000 | (May 16, 2024)